150 related articles for article (PubMed ID: 10379469)
1. Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathy.
Whittle BJ
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S43-7. PubMed ID: 10379469
[TBL] [Abstract][Full Text] [Related]
2. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
Scarpignato C; Pelosini I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of non-steroidal anti-inflammatory drug gastropathy.
Fiorucci S; Antonelli E; Morelli O; Morelli A
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S6-13. PubMed ID: 10379463
[TBL] [Abstract][Full Text] [Related]
5. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
Yeomans ND
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
Lazzaroni M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
[TBL] [Abstract][Full Text] [Related]
8. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
Whittle BJ
Fundam Clin Pharmacol; 2003 Jun; 17(3):301-13. PubMed ID: 12803569
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of non-steroidal anti-inflammatory drug-gastropathy.
Fiorucci S; Antonelli E; Morelli A
Dig Liver Dis; 2001 Dec; 33 Suppl 2():S35-43. PubMed ID: 11827361
[TBL] [Abstract][Full Text] [Related]
11. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drug gastropathy: clinical results with antacids and sucralfate.
Lazzaroni M; Sainaghi M; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S48-53. PubMed ID: 10379470
[TBL] [Abstract][Full Text] [Related]
13. Gastric mucosal defense and cytoprotection: bench to bedside.
Laine L; Takeuchi K; Tarnawski A
Gastroenterology; 2008 Jul; 135(1):41-60. PubMed ID: 18549814
[TBL] [Abstract][Full Text] [Related]
14. Clinical symptoms, endoscopic findings and histologic features of gastroduodenal non-steroidal anti-inflammatory drugs lesions.
Aabakken L
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S19-22. PubMed ID: 10379465
[TBL] [Abstract][Full Text] [Related]
15. [Role of prostaglandins in the pathogenesis of stomach ulcer and gastropathy caused by non-steroid anti-inflammatory drugs].
Lazebnik LB; Tkachenko VN; Kolomiets EV
Eksp Klin Gastroenterol; 2005; (1):4-7, 106. PubMed ID: 15991845
[TBL] [Abstract][Full Text] [Related]
16. Structural damage and changes in eicosanoid metabolites in the gastric mucosa of rats and pigs induced by anti-inflammatory drugs of varying ulcerogenicity.
Rainsford KD
Int J Tissue React; 1986; 8(1):1-14. PubMed ID: 3949439
[TBL] [Abstract][Full Text] [Related]
17. SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
Kim JH; Rhee HI; Jung IH; Ryu K; Jung K; Han CK; Kwak WJ; Cho YB; Joo HJ
Life Sci; 2005 Jul; 77(11):1181-93. PubMed ID: 15935401
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
Wallace JL
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
[TBL] [Abstract][Full Text] [Related]
19. Protocols to assess the gastrointestinal side effects resulting from inhibition of cyclo-oxygenase isoforms.
Whittle BJ
Methods Mol Biol; 2010; 644():189-200. PubMed ID: 20645175
[TBL] [Abstract][Full Text] [Related]
20. Role of prostaglandins in gastroprotection and gastric adaptation.
Brzozowski T; Konturek PC; Konturek SJ; Brzozowska I; Pawlik T
J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():33-55. PubMed ID: 16247188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
